BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24128967)

  • 1. Management of bleeding and reversal strategies for oral anticoagulants: clinical practice considerations.
    Nutescu EA; Dager WE; Kalus JS; Lewin JJ; Cipolle MD
    Am J Health Syst Pharm; 2013 Nov; 70(21):1914-29. PubMed ID: 24128967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical perspectives on the management of bleeding in patients on oral anticoagulants: the DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsal)].
    Vicente V; Martín A; Lecumberri R; Coll-Vinent B; Suero C; González-Porras JR; Marco P; Mateo J; Roldán V; Soulard S; Crespo C; Camats M;
    Emergencias; 2017 Feb; 29(1):18-26. PubMed ID: 28825264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical considerations in emergency management of bleeding in the setting of target-specific oral anticoagulants.
    Miller MP; Trujillo TC; Nordenholz KE
    Am J Emerg Med; 2014 Apr; 32(4):375-82. PubMed ID: 24512886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a management plan for oral anticoagulant reversal.
    Dager WE
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S21-31. PubMed ID: 23640529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic interventions for reversing the effects of oral anticoagulants.
    Kalus JS
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S12-21. PubMed ID: 23640528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New oral anticoagulant-induced bleeding: clinical presentation and management.
    Levy JH; Levi M
    Clin Lab Med; 2014 Sep; 34(3):575-86. PubMed ID: 25168943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Severe Bleeding in Patients Treated With Oral Anticoagulants: Proceedings Monograph From the Emergency Medicine Cardiac Research and Education Group-International Multidisciplinary Severe Bleeding Consensus Panel October 20, 2018.
    Gibler WB; Racadio JM; Hirsch AL; Roat TW
    Crit Pathw Cardiol; 2019 Sep; 18(3):143-166. PubMed ID: 31348075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin and Newer Agents: What the Oral Surgeon Needs to Know.
    Steed MB; Swanson MT
    Oral Maxillofac Surg Clin North Am; 2016 Nov; 28(4):515-521. PubMed ID: 27624772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target-specific oral anticoagulants in patients undergoing cardioversion.
    Law EH; Gordon W
    Am J Health Syst Pharm; 2014 Jul; 71(14):1171-6. PubMed ID: 24973374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current knowledge on assessing the effects of and managing bleeding and urgent procedures with direct oral anticoagulants.
    Dager W; Hellwig T
    Am J Health Syst Pharm; 2016 May; 73(10 Suppl 2):S14-26. PubMed ID: 27147455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral anticoagulant therapies: balancing the risks.
    Nutescu EA
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S3-11. PubMed ID: 23640530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
    Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
    Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants.
    Eikelboom JW; Kozek-Langenecker S; Exadaktylos A; Batorova A; Boda Z; Christory F; Gornik I; Kėkštas G; Kher A; Komadina R; Koval O; Mitic G; Novikova T; Pazvanska E; Ratobilska S; Sütt J; Winder A; Zateyshchikov D
    Br J Anaesth; 2018 Apr; 120(4):645-656. PubMed ID: 29576106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study.
    Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Khuu W; Frymire E; Johnson AP;
    Chest; 2017 Jul; 152(1):81-91. PubMed ID: 28219635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of prescribing conventional and newer oral anticoagulants in older adults.
    Hasan SS; Kow CS; Curley LE; Baines DL; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2018 Aug; 18(4):371-377. PubMed ID: 29741099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New oral anticoagulants in elderly patients with atrial fibrillation.
    Deedwania PC
    Am J Med; 2013 Apr; 126(4):289-96. PubMed ID: 23369212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants.
    Weitz JI; Pollack CV
    Thromb Haemost; 2015 Nov; 114(6):1113-26. PubMed ID: 26155974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants.
    Enriquez A; Lip GY; Baranchuk A
    Europace; 2016 Jul; 18(7):955-64. PubMed ID: 25816811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
    Adachi T; Hoshino H; Takagi M; Fujioka S;
    Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding complications of targeted oral anticoagulants: what is the risk?
    Levine M; Goldstein JN
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):504-9. PubMed ID: 25696901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.